These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37417946)

  • 1. Targeting 2-Oxoglutarate-Dependent Dioxygenases Promotes Metabolic Reprogramming That Protects against Lethal SARS-CoV-2 Infection in the K18-hACE2 Transgenic Mouse Model.
    Jessop F; Schwarz B; Bohrnsen E; Miltko M; Shaia C; Bosio CM
    Immunohorizons; 2023 Jul; 7(7):528-542. PubMed ID: 37417946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
    Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
    J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
    Dedoni S; Avdoshina V; Camoglio C; Siddi C; Fratta W; Scherma M; Fadda P
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.
    Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
    bioRxiv; 2021 Nov; ():. PubMed ID: 34816260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice.
    Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT
    EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19.
    Tian M; Liu W; Li X; Zhao P; Shereen MA; Zhu C; Huang S; Liu S; Yu X; Yue M; Pan P; Wang W; Li Y; Chen X; Wu K; Luo Z; Zhang Q; Wu J
    Signal Transduct Target Ther; 2021 Aug; 6(1):308. PubMed ID: 34408131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal Models of COVID-19: Transgenic Mouse Model.
    Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
    Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1α-Dependent Metabolic Reprogramming, Oxidative Stress, and Bioenergetic Dysfunction in SARS-CoV-2-Infected Hamsters.
    Jana S; Heaven MR; Stauft CB; Wang TT; Williams MC; D'Agnillo F; Alayash AI
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.
    Paull JRA; Luscombe CA; Castellarnau A; Heery GP; Bobardt MD; Gallay PA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy.
    Lennol MP; García-Ayllón MS; Esteban M; García-Arriaza J; Sáez-Valero J
    Front Immunol; 2022; 13():1001951. PubMed ID: 36311758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial antioxidants abate SARS-COV-2 pathology in mice.
    Guarnieri JW; Lie T; Albrecht YES; Hewin P; Jurado KA; Widjaja GA; Zhu Y; McManus MJ; Kilbaugh TJ; Keith K; Potluri P; Taylor D; Angelin A; Murdock DG; Wallace DC
    Proc Natl Acad Sci U S A; 2024 Jul; 121(30):e2321972121. PubMed ID: 39008677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model.
    Cáceres CJ; Cardenas-Garcia S; Carnaccini S; Seibert B; Rajao DS; Wang J; Perez DR
    Sci Rep; 2021 May; 11(1):9609. PubMed ID: 33953295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolized sulfated hyaluronan derivatives prolong the survival of K18 ACE2 mice infected with a lethal dose of SARS-CoV-2.
    Pavan M; Fanti CD; Lucia AD; Canato E; Acquasaliente L; Sonvico F; Delgado J; Hicks A; Torrelles JB; Kulkarni V; Dwivedi V; Zanellato AM; Galesso D; Pasut G; Buttini F; Martinez-Sobrido L; Guarise C
    Eur J Pharm Sci; 2023 Aug; 187():106489. PubMed ID: 37311533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.